Fluoroquinolone resistance in multidrug-resistant tuberculosis patients

被引：2
作者：
Lee, Hyun-Woo [1 ]
Yim, Jae-Joon [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, 101 Daehak Ro, Seoul 03080, South Korea
来源：
KOREAN JOURNAL OF INTERNAL MEDICINE | 2019年 / 34卷 / 02期
关键词：
OUTCOMES;
D O I：
10.3904/kjim.2019.045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：286 / 287
页数：2
相关论文
共 50 条
  • [41] Effects of Treatment Interruption Patterns on Treatment Success Among Patients With Multidrug-Resistant Tuberculosis in Armenia and Abkhazia
    Bastard, Mathieu
    Sanchez-Padilla, Elisabeth
    Hewison, Cathy
    Hayrapetyan, Armen
    Khurkhumal, Shazina
    Varaine, Francis
    Bonnet, Maryline
    JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (10) : 1607 - 1615
  • [42] Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study
    Yuen, Courtney M.
    Kurbatova, Ekaterina V.
    Tupasi, Thelma
    Caoili, Janice Campos
    Van der Walt, Martie
    Kvasnovsky, Charlotte
    Yagui, Martin
    Bayona, Jaime
    Contreras, Carmen
    Leimane, Vaira
    Ershova, Julia
    Via, Laura E.
    Kim, HeeJin
    Akksilp, Somsak
    Kazennyy, Boris Y.
    Volchenkov, Grigory V.
    Jou, Ruwen
    Kliiman, Kai
    Demikhova, Olga V.
    Vasilyeva, Irina A.
    Dalton, Tracy
    Cegielski, J. Peter
    PLOS MEDICINE, 2015, 12 (12):
  • [43] PREVALENCE AND FACTORS ASSOCIATED WITH MULTIDRUG-RESISTANT TUBERCULOSIS AT SIRIRAJ HOSPITAL, BANGKOK, THAILAND
    Jitmuang, Anupop
    Munjit, Parnwad
    Foongladda, Suporn
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2015, 46 (04) : 697 - 706
  • [44] Linezolid Pharmacokinetics/Pharmacodynamics-Based Optimal Dosing for Multidrug-Resistant Tuberculosis
    Zhou, Wenqiang
    Nie, Wenjuan
    Wang, Qingfeng
    Shi, Wenhui
    Yang, Yang
    Li, Qi
    Zhu, Hui
    Liu, Zhongquan
    Ding, Yangming
    Lu, Yu
    Chu, Naihui
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (06)
  • [45] Treatment of multidrug-resistant pulmonary tuberculosis with delamanid based on Japanese guideline recommendations
    Okumura, Masao
    Yoshiyama, Takashi
    Ogata, Hideo
    Kurashima, Atsuyuki
    Yoshimori, Kozo
    Ohta, Ken
    Kudoh, Shoji
    RESPIRATORY INVESTIGATION, 2020, 58 (02) : 110 - 116
  • [46] Sequelae of multidrug-resistant tuberculosis: protocol for a systematic review and meta-analysis
    Alene, Kefyalew Addis
    Clements, Archie C. A.
    McBryde, Emma S.
    Jaramillo, Ernesto
    Lonnroth, Knut
    Shaweno, Debebe
    Viney, Kerri
    BMJ OPEN, 2018, 8 (02):
  • [47] Epidemiology of Pediatric Multidrug-Resistant Tuberculosis in the United States, 1993-2014
    Smith, Sarah E.
    Pratt, Robert
    Trieu, Lisa
    Barry, Pennan M.
    Thai, Dzung T.
    Ahuja, Shama Desai
    Shah, Sarita
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (09) : 1437 - 1443
  • [48] Primary bacillary resistance in multidrug-resistant tuberculosis and predictive factors associated with cure at a referral center in Sao Paulo, Brazil
    Guimaraes Savioli, Marcia Telma
    Morrone, Nelson
    Santoro, Ilka
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2019, 45 (02) : e20180075
  • [49] Rapid drug susceptibility testing and treatment outcomes for multidrug-resistant tuberculosis in Peru
    Obregon, G.
    Zevallos, K.
    Alarcon, V
    Puyen, Z. M.
    Chavez Inagaki, O.
    Mendoza-Ticona, A.
    Alarcon-Arrascue, E.
    Heldal, E.
    Moore, D. A. J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (11) : 1350 - +
  • [50] Evaluation of Saliva as a Potential Alternative Sampling Matrix for Therapeutic Drug Monitoring of Levofloxacin in Patients with Multidrug-Resistant Tuberculosis
    Ghimire, Samiksha
    Maharjan, Bhagwan
    Jongedijk, Erwin M.
    Kosterink, Jos G. W.
    Ghimire, Gokarna R.
    Touw, Daan J.
    van der Werf, Tjip S.
    Shrestha, Bhabana
    Alffenaar, Jan-Willem C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (05)
12345